NCT04921488 (IA COLO) is a NA clinical trial of screening colonoscopy in Colonoscopy, sponsored by University Hospital, Bordeaux.

Who is sponsoring NCT04921488?

NCT04921488 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT04921488?

Interventions in NCT04921488: screening colonoscopy.

What condition does NCT04921488 study?

NCT04921488 studies Colonoscopy, Colorectal Neoplasms, Intestinal Polyps, Deep Learning.

Is NCT04921488 still recruiting?

NCT04921488 is currently completed. Last updated 13 March 2023.

Last reviewed 2023-03-13 · How we verify

NCT04921488: IA COLO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interest of Artificial Intelligence in Cancer Screening Colonoscopy

Completed NA Last updated 13 March 2023

What this trial tests

NA trial testing screening colonoscopy in Colonoscopy in 194 participants. Completed in 25 January 2023.

Timeline

21 October 2021

Primary endpoint
25 January 2023

25 January 2023

Quick facts

Lead sponsor	University Hospital, Bordeaux
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	194
Start date	21 October 2021
Primary completion	25 January 2023
Estimated completion	25 January 2023
Sites	5 locations across France

Drugs / interventions tested

screening colonoscopy — full drug profile →

Conditions studied

Colonoscopy — all drugs for Colonoscopy →
Colorectal Neoplasms — all drugs for Colorectal Neoplasms →
Intestinal Polyps — all drugs for Intestinal Polyps →
Deep Learning — all drugs for Deep Learning →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Colonoscopy or Colorectal Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Artificial Intelligence (AI) to predict the histology of polyps per colonoscopy, offers a promising solution to reduce variation in colonoscopy performance. This new and innovative non-invasive technology will improve the quality of screening colonoscopies, and reduce the costs of colorectal cancer screening. The aim of the study is to performed a cross-sectional, multi-center study evaluating the diagnostic performance of the CAD EYE automatic characterization system for the histology of colonic polyps in colorectal cancer screening colonoscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Real-Time Characterization of Colonic Polyps: A Multicenter Prospective Study Evaluating the CAD-EYE System in Screening Colonoscopies.
Maigné M, Saunier M, Renaudeau V, Dray X, et al · · 2026 · PMID 41563136 · DOI 10.14309/ctg.0000000000000976

Verify or expand the search:

Other trials of screening colonoscopy

Trials testing the same drug.

NCT00625066 — Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing · completed
NCT00102011 — Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer · Phase 3 · completed

Other recruiting trials for Colonoscopy

Currently open trials in the same condition.

NCT07353853 — Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease · NA · recruiting
NCT07335705 — Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients · recruiting
NCT06763705 — Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy · Phase 4 · recruiting
NCT07171853 — The Carbon Footprint Study of Colonoscopy · recruiting
NCT07355777 — Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation · NA · recruiting

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04921488 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 13 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04921488.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing